Profilo
Marie-Noëlle Ip worked as a Program Director at the Council of Canadian Academies, an Operations Director at Verlyx Pharma, Inc., and a Principal at BCE, Inc. from 1989 to 2003.
Precedenti posizioni note di Marie-Noëlle Ip
| Società | Posizione | Fine |
|---|---|---|
| BCE INC. | Corporate Officer/Principal | 01/01/2003 |
| Council of Canadian Academies | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BCE INC. | Communications |
| Aziende private | 2 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
| Council of Canadian Academies |
- Borsa valori
- Insiders
- Marie-Noëlle Ip
